ArticleTranslational andrology and urology2026
Characterizing dementia among patients with spina bifida (SB).
Article in Translational andrology and urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Background: Little is known about dementia among patients with spina bifida (SB). In this study we aim to characterize demographics and subtypes of dementia among individuals with SB compared to the general population. Methods: We utilized the Department of Health Care Access and Information (HCAI) database to capture all inpatient encounters at California-licensed hospitals from 2005-2017. Two distinct analyses were performed: (I) comparing patients with dementia who had SB (n=528) to frequency-matched non-SB dementia controls (n=1,451), and (II) comparing SB patients with dementia (n=528) to frequency-matched SB patients without dementia (n=929). Patients with <50 years of age, missing linkage, missing birthdate, or non-California address were excluded. Demographic, socioeconomic, and healthcare-related variables were compared using Pearson's Chi-squared test and 2-tailed Results: Our analytic cohort consisted of a SB with dementia group (n=528), a non-SB with dementia control group (n=1,451), and an SB without dementia comparison group (n=929). In the dementia cohort, the SB group had lower proportions of all-cause dementia (80% Conclusions: In this population-level study, we characterize dementia among patients with SB relative to the general population and its impact on healthcare utilization. Our study elucidates differences in the types of dementia SB patients experience as well as racial and socioeconomic differences relative to the general population. Further research will address the impact of dementia on healthcare outcomes among patients with SB.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.